[Can stereotactic radiotherapy for neovascular age-related macular degeneration (STAR trial) enhance quality of life?].

Strahlenther Onkol

Klinik für Radioonkologie und Strahlentherapie, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-024-02351-2DOI Listing

Publication Analysis

Top Keywords

[can stereotactic
4
stereotactic radiotherapy
4
radiotherapy neovascular
4
neovascular age-related
4
age-related macular
4
macular degeneration
4
degeneration star
4
star trial
4
trial enhance
4
enhance quality
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!